IDXX — IDEXX Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- $41.20bn
- $41.74bn
- $3.66bn
- 96
- 11
- 66
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 90.3 | 384 | 144 | 113 | 454 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 307 | 375 | 426 | 491 | 530 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 680 | 1,063 | 956 | 1,101 | 1,495 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 614 | 646 | 693 | 768 | 818 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,832 | 2,295 | 2,437 | 2,747 | 3,260 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 725 | 583 | 764 | 1,236 | 952 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,655 | 1,662 | 1,747 | 2,138 | 1,775 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 177 | 632 | 690 | 609 | 1,485 |
Total Liabilities & Shareholders' Equity | 1,832 | 2,295 | 2,437 | 2,747 | 3,260 |
Total Common Shares Outstanding |